Proanthocyanidin intake is inversely associated with advanced prostate tumor stages in newly diagnosed prostate cancer patients
Ying Wang(Hebei Medical University), Ock K. Chun(University of Connecticut), Terrence M. Vance(Brown University), James L. Mohler, Ming‐Hui Chen(University of British Columbia), Elizabeth T. H. Fontham(Louisiana State University), Joseph Su(The University of Texas Southwestern Medical Center), Jeannette T. Bensen(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
|CA A Cancer Journal for Clinicians|2020|966
Prostate Cancer
|Journal of the National Comprehensive Cancer Network|2010|902
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
|Journal of the National Comprehensive Cancer Network|2016|345